Monte Rosa Therapeutics annual total assets
2020
2021
2022
2023
2024
2025
Monte Rosa Therapeutics Total Assets Growth & History (GLUE)
Monte Rosa Therapeutics's total assets was $448.7M for fiscal 2025.
View full Monte Rosa Therapeutics company overviewMonte Rosa Therapeutics annual total assets history
| Fiscal year | Period ended | Total assets | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $448.7M | $9.9M | +2.26% |
| 2024 | 2024-12-31 | $438.7M | $135.0M | +44.44% |
| 2023 | 2023-12-31 | $303.8M | −$38.6M | −11.28% |
| 2022 | 2022-12-31 | $342.4M | −$23.9M | −6.54% |
| 2021 | 2021-12-31 | $366.3M | $317.0M | +641.89% |
| 2020 | 2020-12-31 | $49.4M | — | — |
Monte Rosa Therapeutics quarterly total assets
Q4.20
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Total assets | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $691.2M | $331.6M | +92.21% |
| Q1 2026 | 2026-03-31 | $736.4M | $343.2M | +87.29% |
| Q4 2025 | 2025-12-31 | $448.7M | $9.9M | +2.26% |
| Q3 2025 | 2025-09-30 | $459.8M | $144.8M | +45.94% |
| Q2 2025 | 2025-06-30 | $359.6M | $15.5M | +4.50% |
| Q1 2025 | 2025-03-31 | $393.2M | $126.5M | +47.41% |
| Q4 2024 | 2024-12-31 | $438.7M | $135.0M | +44.44% |
| Q3 2024 | 2024-09-30 | $315.1M | $63.0M | +24.98% |
| Q2 2024 | 2024-06-30 | $344.1M | $65.5M | +23.51% |
| Q1 2024 | 2024-03-31 | $266.7M | −$42.3M | −13.68% |
| Q4 2023 | 2023-12-31 | $303.8M | −$38.6M | −11.28% |
| Q3 2023 | 2023-09-30 | $252.1M | −$105.5M | −29.50% |
| Q2 2023 | 2023-06-30 | $278.6M | −$86.4M | −23.68% |
| Q1 2023 | 2023-03-31 | $309.0M | −$37.0M | −10.69% |
| Q4 2022 | 2022-12-31 | $342.4M | −$23.9M | −6.54% |
| Q3 2022 | 2022-09-30 | $357.6M | −$26.4M | −6.89% |
| Q2 2022 | 2022-06-30 | $365.1M | −$3.9M | −1.05% |
| Q1 2022 | 2022-03-31 | $346.0M | — | — |
| Q4 2021 | 2021-12-31 | $366.3M | $317.0M | +641.89% |
| Q3 2021 | 2021-09-30 | $384.0M | — | — |
| Q2 2021 | 2021-06-30 | $368.9M | — | — |
| Q4 2020 | 2020-12-31 | $49.4M | — | — |
Monte Rosa Therapeutics total assets trends
Over the last five fiscal years, Monte Rosa Therapeutics's total assets increased from $49.4M to $448.7M, a change of $399.3M. The latest reported quarter, Q2 2026, shows $691.2M.
About the metric
What total assets mean
Total assets are the resources a company controls at a reporting-period end, including cash, investments, receivables, inventory, property, intangible assets, and other reported assets. The composition of assets differs substantially by industry.
Calculation and source
SEC-reported total assets
TickerStat uses total assets reported in company SEC filings. When a filer provides the equivalent balance-sheet total as liabilities and equity, that reported amount is used because total assets must equal total liabilities plus equity. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Monte Rosa Therapeutics source filings ↗